Supawat Thongthip
Stock Analyst at Truist Financial
(2.60)
# 2,865
Out of 4,468 analysts
5
Total ratings
80%
Success rate
16.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Supawat Thongthip
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Initiated Coverage: Buy | $26 | $15.54 | +67.31% | 1 | Jun 25, 2026 | |
| STRO Sutro Biopharma | Initiated Coverage: Buy | $50 | $30.43 | +64.31% | 1 | Jun 11, 2026 | |
| RCUS Arcus Biosciences | Maintained: Buy | n/a | $30.33 | - | 2 | Jun 4, 2026 | |
| IMNM Immunome | Initiated Coverage: Buy | $37 | $23.61 | +56.71% | 1 | May 28, 2026 |
Janux Therapeutics
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $15.54
Upside: +67.31%
Sutro Biopharma
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $30.43
Upside: +64.31%
Arcus Biosciences
Jun 4, 2026
Maintained: Buy
Price Target: n/a
Current: $30.33
Upside: -
Immunome
May 28, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $23.61
Upside: +56.71%